InMode remains a highly profitable company, though success cooled in late 2023, with the company starting to miss estimates and revenue shrinking. The majority of revenue comes from the United States, with products sold in 14+ countries through distributors.
Cyborg Score Rationale
The company had accumulated $1 billion cash from operations until a year ago, indicating strong balance sheet fundamentals. However, recent headwinds have pressured valuation and growth prospects.
Top Insights
Current share price down 84% from peak of $7B+ market cap, now valued at $950M
2025 revenue was $370.5M, down 6.16% year-over-year
Product portfolio includes BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8